ArticleDiabetes, obesity & metabolism2026

Proteins and signalling pathways targeted by dapagliflozin and finerenone: Insights from DAPA-CKD and FIGARO-DKD.

Mark André de la Rambelje et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.